Methods Mentioned
BETA
flow cytometry
Software Mentioned
Cell Quest
SPSS
GeneMapper
SPSS® Statistics
Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Cancer Biomarkers : Section a of Disease Markers
Salah ArefMohamed Sabry
Advances in Hematology
Salah ArefMohamed S El-Ghonemy
Seminars in Oncology
Claudia D Baldus, Lars Bullinger
Cancers
Ludovic GabellierJérôme Moreaux